- Celcuity wins approval for breast cancer drug RevtorpykA small public biotech won approval for a breast cancer drug that was designed to improve on similar treatments from Novartis and Roche. The FDA on Tuesday cleared Celcuity's Revtorpyk in combina…Endpoints · 13d ago↗ source
- What's next for BINSA, the House bill restricting China dealsAfter setting the industry ablaze last month, a bipartisan bill aimed at restricting US biotech companies from striking deals with Chinese counterparts is in limbo. The Biotech Investment Nationa…Endpoints · 13d ago↗ source
- Post-Hoc Live: What’s making biotech IPOs work again?Late last year, I found myself talking a lot about what it would take for biotech’s budding rally to become a full one. We had deals, good pipeline readouts and a rising public stock market ...